BridgeMD
New treatment option for Lower Limbs Peripheral Arterial Disease
Official title Feasibility Study of an Angiographic Quantitative Flow Ratio-guided Endovascular Procedure in Patients With Lower Limbs Peripheral Arterial Disease.
ClinicalTrials.gov ID: NCT06516315
What this study is testing
- What it's testing
- The main objective of this study is to explore the feasibility of using the angiographic Quantitative Flow Ratio (QFR) as a tool to predict the success rate of endovascular revascularization in patients with superficial artery disease. This is a prospective feasibility study.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patient with symptomatic Rutherford stage 2 to 6 AOMI with an indication for endovascular revascularization
- Patient with a simple lesion (TASC A) and short stenosis of the superficial femoral artery
- Patient affiliated to a health insurance system
- French-speaking patient
- Patient with free, informed and express oral consent
You likely can't join if
- Renal failure patients with GFR \< 30 ml/min
- Patient deprived of liberty
- Patients under court protection
- Pregnant or breast-feeding patients
The study team makes the final eligibility decision.
Where it's taking place
- Paris, Île-de-France Region, France
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Paris, Île-de-France Region, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.